$NASDAQ:ILMN - analysis of annual cot levelsNASDAQ:ILMN
Please remember that this idea does not constitute investment advice.
After a personal analysis of the institutional value of the COT, buy and sell program levels are outlined. Since the asset is at its minimum, the idea is to wait for the price to head inside the buy program, wait fo
Key facts today
Illumina partners with Tempus AI to improve next-gen sequencing tests, using AI and data to enhance genomic algorithms and standardize molecular testing for major diseases.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−6.980 CHF
−1.11 B CHF
3.97 B CHF
153.56 M
About Illumina, Inc.
Sector
Industry
CEO
Jacob Thaysen
Website
Headquarters
San Diego
Founded
1998
FIGI
BBG00LVDL104
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
ILMN Illumina Options Ahead of Earnings Analyzing the options chain and the chart patterns of ILMN Illumina prior to the earnings report this week,
I would consider purchasing the 140usd strike price in the money Calls with
an expiration date of 2024-12-20,
for a premium of approximately $16.65.
If these options prove to be profitable pri
ILMN Long PositionHi traders,
Taking a closer look at Illumina, Inc. (ILMN), we can observe the formation of a falling wedge pattern over the past few weeks, indicating a potential bullish reversal.
Illumina, a leading developer of life science tools and integrated systems for large-scale analysis of genetic variati
ILMN Bullish ComebackOn the 12 month timeframe, or yearly supercycle, ILMN seems to be consolidating enough these first 3 months into 2024 to ultimately flip to the upside with maximum bull force. The company has a solid catalyst with AI facilitating the end goal of a super biopharma product that perhaps all humanity ma
Ending diagonal heralds the beginning of a prolonged bear marketAn ending diagonal starting from March 2020 is seen on the chart for ILLUMINA. This pattern usually signals exhaustion at the end of a bull cycle and the start of a bear market. As seen on the log scale (monthly or weekly), ILLUMINA has been slowly losing momentum for the past decade. Although it
ILMN Illumina Options Ahead of EarningsAnalyzing the options chain and the chart patterns of ILMN Illumina prior to the earnings report this week,
I would consider purchasing the 195usd strike price Calls with
an expiration date of 2023-9-15,
for a premium of approximately $8.15.
If these options prove to be profitable prior to the earni
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
ILMN5150650
Illumina, Inc. 2.55% 23-MAR-2031Yield to maturity
6.01%
Maturity date
Mar 23, 2031
ILMN5508412
Illumina, Inc. 5.75% 13-DEC-2027Yield to maturity
5.01%
Maturity date
Dec 13, 2027
ILMN5508411
Illumina, Inc. 5.8% 12-DEC-2025Yield to maturity
4.81%
Maturity date
Dec 12, 2025
ILMN5886317
Illumina, Inc. 4.65% 09-SEP-2026Yield to maturity
4.75%
Maturity date
Sep 9, 2026
See all ILU bonds
Curated watchlists where ILU is featured.
Related stocks
Frequently Asked Questions
The current price of ILU is 65.125 CHF — it has increased by 5.58% in the past 24 hours. Watch ILLUMINA INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange ILLUMINA INC stocks are traded under the ticker ILU.
ILU stock has fallen by −14.04% compared to the previous week, the month change is a −8.63% fall, over the last year ILLUMINA INC has showed a −44.82% decrease.
We've gathered analysts' opinions on ILLUMINA INC future price: according to them, ILU price has a max estimate of 155.09 CHF and a min estimate of 61.22 CHF. Watch ILU chart and read a more detailed ILLUMINA INC stock forecast: see what analysts think of ILLUMINA INC and suggest that you do with its stocks.
ILU stock is 5.29% volatile and has beta coefficient of 0.89. Track ILLUMINA INC stock price on the chart and check out the list of the most volatile stocks — is ILLUMINA INC there?
Today ILLUMINA INC has the market capitalization of 9.70 B, it has decreased by −8.66% over the last week.
Yes, you can track ILLUMINA INC financials in yearly and quarterly reports right on TradingView.
ILLUMINA INC is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
ILU earnings for the last quarter are 0.86 CHF per share, whereas the estimation was 0.83 CHF resulting in a 4.07% surprise. The estimated earnings for the next quarter are 0.83 CHF per share. See more details about ILLUMINA INC earnings.
ILLUMINA INC revenue for the last quarter amounts to 1.00 B CHF, despite the estimated figure of 986.06 M CHF. In the next quarter, revenue is expected to reach 908.61 M CHF.
ILU net income for the last quarter is 169.83 M CHF, while the quarter before that showed 597.44 M CHF of net income which accounts for −71.57% change. Track more ILLUMINA INC financial stats to get the full picture.
No, ILU doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 16, 2025, the company has 10.37 K employees. See our rating of the largest employees — is ILLUMINA INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ILLUMINA INC EBITDA is 1.39 B CHF, and current EBITDA margin is 17.25%. See more stats in ILLUMINA INC financial statements.
Like other stocks, ILU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ILLUMINA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ILLUMINA INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ILLUMINA INC stock shows the strong sell signal. See more of ILLUMINA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.